glycogen synthase kinase 3 beta inhibitors (PsychoGenics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameglycogen synthase kinase 3 beta inhibitors (PsychoGenics)
Drug Alias NameGSK-3beta inhibitors (PsychoGenics)GSK-3beta inhibitors (PsychoGenics)ING-135
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsBipolar DisorderParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPsychoGenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPsychoGenics Inc
Active IndicationsN/A
Inactive IndicationsBipolar DisorderParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A